Psoriasis: open trials in United States

69 open trials have a site in United States. Registry data; only the trial team decides who can take part.

NCT07280702
Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
Trial Treatment · Phase 4 · University of Texas Southwestern Medical Center
UT Southwestern Medical Center, Dallas
Registry updated 2026-09-01
NCT02707341
The CorEvitas Psoriasis (PSO) Registry
Research · CorEvitas
Waltham
Registry updated 2026-08-27
NCT07615712
PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study
Research · CorEvitas
CorEvitas, LLC, Waltham
Registry updated 2026-08-26
NCT07648602
PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study
Research · CorEvitas
CorEvitas, LLC, Waltham
Registry updated 2026-08-26
NCT07180537
Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
Trial Treatment · Terry L. Wahls
Univeristy of Iowa, Iowa City
Registry updated 2026-08-10
NCT07744191
A Clinical Trial of Antiplatelets in Psoriasis
Trial Treatment · Phase 4 · NYU Langone Health
NYU Langone Health, New York
Registry updated 2026-08-05
NCT05981118
Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)
Trial Treatment · Phase 2/3 · Wake Forest University Health Sciences
Wake Forest University Health Sciences Department of Dermatology, Winston-Salem
Registry updated 2026-08-04
NCT07390487
The Effects of Audio-Based Therapy on Anxiety in Psoriasis
Trial Treatment · University of California, San Francisco
Liao Lab at UCSF, San Francisco
Registry updated 2026-07-23
NCT04170244
Skin Microbial Ecology in Atopic Dermatitis
Research · University of Rochester
University of Rochester Medical Center, Rochester
Registry updated 2026-07-14
NCT07138898
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Trial Treatment · Phase 2 · NYU Langone Health
NYU Langone Health, New York
Registry updated 2026-07-09
NCT07489885
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Trial Treatment · Phase 2 · InventisBio Co., Ltd
Birmingham · Chula Vista · Clarksville · Fort Lauderdale · Fountain Valley · Fremont · Idaho Falls · Los Angeles · Louisville · Mayfield Heights · Miramar · Ocala · Philadelphia · Phoenix · San Antonio · San Diego · Sandy Springs · Savannah · Tampa
Registry updated 2026-07-09
NCT06574178
Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
Trial Treatment · University of California, Davis
University of California, Davis - Dermatology Department, Sacramento
Registry updated 2026-06-16
NCT06586281
Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
Trial Treatment · University of California, San Diego
University of California San Diego, San Diego
Registry updated 2026-06-10
NCT05390515
Psoriatic Immune Response to Tildrakizumab
Trial Treatment · Phase 4 · University of California, San Francisco
University of California San Francisco, San Francisco
Registry updated 2026-06-04
NCT05858632
Immune Spatial Features of Guselkumab Cutaneous Response
Trial Treatment · Phase 4 · University of California, San Francisco
University of California San Francisco, San Francisco
Registry updated 2026-06-04
NCT05858645
Correction of Psoriatic T Cell Signatures by Deucravacitinib
Trial Treatment · Phase 4 · University of California, San Francisco
University of California San Francisco, San Francisco
Registry updated 2026-06-04
NCT07352566
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
Trial Treatment · Phase 4 · University of California, San Francisco
University of California San Francisco, San Francisco
Registry updated 2026-06-03
NCT04751396
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Research · M.D. Anderson Cancer Center
M D Anderson Cancer Center, Houston
Registry updated 2026-05-20
NCT03125655
Regulation of Inflammatory Genes in Psoriasis
Research · University of Alabama at Birmingham
The Kirklin Clinic, Birmingham
Registry updated 2026-04-06
NCT06454188
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
Trial Treatment · Phase 4 · CARE ARTHRITIS LTD.
University Hospitals Cleveland Medical Center*, Cleveland · University of Pennsylvania, Philadelphia · Oregon Health and Science University, Portland
Registry updated 2026-04-03
NCT05270733
Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
Trial Treatment · Phase 4 · University Hospitals Cleveland Medical Center
University Hospitals Cleveland Medical Center*, Cleveland
Registry updated 2026-04-02
NCT05004727
Multi-Center PAMPA Study
Trial Treatment · Phase 4 · NYU Langone Health
Brigham and Women's Hospital, Boston · NYU Langone Health, New York · University of Rochester Medical Center (URMC), Rochester
Registry updated 2026-03-30
NCT07471048
A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis
Trial Treatment · Sirt3 LLC
Decentralized Study Coordinating Center, Englewood
Registry updated 2026-03-13
NCT07426120
Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-III)
Trial Treatment · Phase 3 · Psoriasis Research Institute of Guangzhou
Department of Dermatology, SUNY Downstate Health Sciences University, New York
Registry updated 2026-02-23
NCT04036188
Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis
Trial Treatment · Early phase 1 · Wright State University
Wright State Physicians, Fairborn
Registry updated 2026-02-19

All Psoriasis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error